John Leite, Chief Commercial Officer at Veracyte, Inc. (VCYT), sold shares on the open market five times over the past year for a total of $551,475. His latest VCYT sale occurred on March 4, 2026. These transactions rank 6,225th among 11,678 individual insiders, trailing the average sale value of $8.6 million across 6.37 transactions. Leite made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 6, 2026 | VERACYTE, INC. | $VCYT | Leite John | Chief Commercial Officer-CLIA | A | Common Stock | 6578 | $0.00 | 150,339.0000 | 79,946,386 | 4.58% | 0.01% |
| March 6, 2026 | VERACYTE, INC. | $VCYT | Leite John | Chief Commercial Officer-CLIA | A | Common Stock | 36181 | $0.00 | 143,761.0000 | 79,946,386 | 33.63% | 0.05% |
| March 4, 2026 | VERACYTE, INC. | $VCYT | Leite John | Chief Commercial Officer-CLIA | S | Common Stock | 5260 | $35.19 | 107,580.0000 | 79,946,386 | 4.66% | 0.01% |
| March 2, 2026 | VERACYTE, INC. | $VCYT | Leite John | Chief Commercial Officer-CLIA | F | Common Stock | 7517 | $36.01 | 112,840.0000 | 79,946,386 | 6.25% | 0.01% |
| Feb. 26, 2026 | VERACYTE, INC. | $VCYT | Leite John | Chief Commercial Officer-CLIA | A | Common Stock | 47149 | $0.00 | 129,262.0000 | 79,946,386 | 57.42% | 0.06% |
| Feb. 26, 2026 | VERACYTE, INC. | $VCYT | Leite John | Chief Commercial Officer-CLIA | F | Common Stock | 8905 | $38.75 | 120,357.0000 | 79,946,386 | 6.89% | 0.01% |
| Dec. 2, 2025 | VERACYTE, INC. | $VCYT | Leite John | Chief Commercial Officer-CLIA | F | Common Stock | 2900 | $46.16 | 83,391.0000 | 79,946,386 | 3.36% | 0.00% |
| Dec. 4, 2025 | VERACYTE, INC. | $VCYT | Leite John | Chief Commercial Officer-CLIA | S | Common Stock | 1278 | $47.51 | 82,113.0000 | 79,946,386 | 1.53% | 0.00% |
| Nov. 25, 2025 | VERACYTE, INC. | $VCYT | Leite John | Chief Commercial Officer-CLIA | S | Common Stock | 2808 | $50.00 | 86,291.0000 | 79,946,386 | 3.15% | 0.00% |
| Oct. 1, 2025 | VERACYTE, INC. | $VCYT | Leite John | Chief Commercial Officer-CLIA | S | Common Stock | 2539 | $35.00 | 89,099.0000 | 79,946,386 | 2.77% | 0.00% |
| Sept. 2, 2025 | VERACYTE, INC. | $VCYT | Leite John | Chief Commercial Officer-CLIA | F | Common Stock | 2902 | $30.11 | 91,638.0000 | 78,163,217 | 3.07% | 0.00% |
| June 4, 2025 | VERACYTE, INC. | $VCYT | Leite John | Chief Commercial Officer-CLIA | S | Common Stock | 2809 | $27.20 | 94,540.0000 | 78,163,217 | 2.89% | 0.00% |
| June 2, 2025 | VERACYTE, INC. | $VCYT | Leite John | Chief Commercial Officer-CLIA | F | Common Stock | 2900 | $26.74 | 97,349.0000 | 78,163,217 | 2.89% | 0.00% |
| March 7, 2025 | VERACYTE, INC. | $VCYT | Leite John | Chief Commercial Officer-CLIA | S | Common Stock | 5011 | $31.96 | 100,249.0000 | 78,163,217 | 4.76% | 0.01% |
| March 6, 2025 | VERACYTE, INC. | $VCYT | Leite John | Chief Commercial Officer-CLIA | A | Common Stock | 36240 | $0.00 | 107,660.0000 | 78,163,217 | 50.74% | 0.05% |
| March 7, 2025 | VERACYTE, INC. | $VCYT | Leite John | Chief Commercial Officer-CLIA | S | Common Stock | 2400 | $31.04 | 105,260.0000 | 78,163,217 | 2.23% | 0.00% |
| Feb. 27, 2025 | VERACYTE, INC. | $VCYT | Leite John | Chief Commercial Officer-CLIA | S | Common Stock | 5746 | $33.84 | 79,070.0000 | 78,163,217 | 6.77% | 0.01% |
| Feb. 27, 2025 | VERACYTE, INC. | $VCYT | Leite John | Chief Commercial Officer-CLIA | A | Common Stock | 11006 | $0.00 | 84,816.0000 | 78,163,217 | 14.91% | 0.01% |
| March 2, 2025 | VERACYTE, INC. | $VCYT | Leite John | Chief Commercial Officer-CLIA | F | Common Stock | 7650 | $34.76 | 71,420.0000 | 78,163,217 | 9.67% | 0.01% |
| Dec. 2, 2024 | VERACYTE, INC. | $VCYT | Leite John | Chief Commercial Officer-CLIA | F | Common Stock | 1314 | $44.12 | 74,860.0000 | 78,465,000 | 1.72% | 0.00% |
| Dec. 3, 2024 | VERACYTE, INC. | $VCYT | Leite John | Chief Commercial Officer-CLIA | S | Common Stock | 1050 | $43.25 | 73,810.0000 | 78,465,000 | 1.40% | 0.00% |
| Sept. 4, 2024 | VERACYTE, INC. | $VCYT | Leite John | Chief Commercial Officer-CLIA | S | Common Stock | 5479 | $29.78 | 76,174.0000 | 72,644,487 | 6.71% | 0.01% |
| Sept. 2, 2024 | VERACYTE, INC. | $VCYT | Leite John | Chief Commercial Officer-CLIA | F | Common Stock | 1315 | $31.55 | 81,653.0000 | 72,644,487 | 1.58% | 0.00% |
| July 16, 2024 | VERACYTE, INC. | $VCYT | Leite John | Chief Commercial Officer-CLIA | S | Common Stock | 1277 | $25.00 | 82,968.0000 | 72,644,487 | 1.52% | 0.00% |
| June 2, 2024 | VERACYTE, INC. | $VCYT | Leite John | Chief Commercial Officer-CLIA | F | Common Stock | 1314 | $20.75 | 84,245.0000 | 72,644,487 | 1.54% | 0.00% |
| March 6, 2024 | VERACYTE, INC. | $VCYT | Leite John | Chief Commercial Officer-CLIA | A | Common Stock | 49880 | $0.00 | 85,559.0000 | 72,644,487 | 139.80% | 0.07% |
| March 2, 2024 | VERACYTE, INC. | $VCYT | Leite John | Chief Commercial Officer-CLIA | F | Common Stock | 3008 | $24.00 | 35,679.0000 | 72,644,487 | 7.78% | 0.00% |
| Dec. 2, 2023 | VERACYTE, INC. | $VCYT | Leite John | Chief Commercial Officer-CLIA | F | Common Stock | 556 | $26.54 | 38,687.0000 | 71,549,204 | 1.42% | 0.00% |
| Sept. 2, 2023 | VERACYTE, INC. | $VCYT | Leite John | Chief Commercial Officer-CLIA | F | Common Stock | 2222 | $26.70 | 39,243.0000 | 71,549,204 | 5.36% | 0.00% |